Medication info

Aminoplasma 5% Injection

Prescription medicationInjections
Ingredient · strength
L-Isoleucine›0.25g / 100mLL-Leucine›0.445g / 100mLLysine Hydrochloride›0.428g / 100mLL-Methionine›0.22g / 100mLL-Phenylalanine›0.235g / 100mLL-Threonine›0.21g / 100mLL-Tryptophan›0.08g / 100mLL-Valine›0.31g / 100mLL-Arginine›0.575g / 100mLL-Histidine›0.15g / 100mLL-Alanine›0.525g / 100mLL-Aspartic Acid›0.28g / 100mLL-Glutamic Acid›0.36g / 100mLGlycine›0.6g / 100mLL-Proline›0.275g / 100mLL-Serine›0.115g / 100mLL-Tyrosine›0.04g / 100mLSodium Acetate Hydrate›0.1361g / 100mLSodium Hydroxide›0.014g / 100mLPotassium Acetate›0.2453g / 100mLSodium Chloride›0.0965g / 100mLMagnesium Chloride Hydrate›0.0508g / 100mLSodium Phosphate›0.3581g / 100mL
Manufacturer / importer
B.Braun Korea Co., Ltd
Appearance
A colorless transparent or pale yellow aqueous solution in a colorless transparent glass vial.
Packaging
250 ml/bottle, 500 ml/bottle, 1000 ml/bottle
Approval status
Active

MFDS item code 201604146 · Approved 2016.06.30

Summary

Main use
Improvement of nutritional deficiency through supplementation with amino acids and small amounts of electrolytes
Who uses it
Adults · Children
Adult dosage
The intravenous dose depends on the patient's clinical condition and requirements for amino acids, electrolytes, and fluids (nutritional status and/or the degree of nitrogen catabolism due to disease). ○ Children 14 years and older and adults: -Daily dose: Administer 1~2 g of amino acids per kg of body weight daily. This corresponds to 20~40 mL of this medicine per kg of body weight daily; for a patient weighing 70 kg, administer 1,400~2,800 mL daily. -Maximum daily dose: Up to 40 mL (2 g of amino acids) per kg of body weight daily; for a patient weighing 70 kg, up to 2,800 mL (140 g of amino acids) may be administered daily. -Maximum infusion rate: Up to 2 mL (0.1 g of amino acids) per kg of body weight over 1 hour; for a patient weighing 70 kg, this is 45 drops per minute or 2.34 mL. Patients with renal or hepatic impairment The dose should be adjusted accordingly in patients with hepatic or renal failure. This medicine is contraindicated in patients with severe hepatic or renal failure. If the amino acid requirement is 1 g or more per kg of body weight daily, caution should be exercised regarding fluid load; in some cases, this medicine may be replaced with a solution with a higher amino acid concentration. Administer by intravenous infusion. This medicine may be administered through a peripheral vein.
Children's dosage
Children aged 2 years or older and younger than 5 years: 30 mL (1.5 g of amino acids) per kg of body weight daily. Children aged 5 years or older and younger than 14 years: 20 mL (1.0 g of amino acids) per kg of body weight daily. The maximum infusion rate in children aged 2 years or older and younger than 14 years is up to 2 mL (0.1 g of amino acids) per kg of body weight over 1 hour. For critically ill children (aged 2 years or older and younger than 12 years), a higher dose of amino acids may be required (up to 3.0 g of amino acids/kg body weight daily).

Ingredients

Importer
B.Braun Korea Co., Ltd

Efficacy & effects

Improvement of nutritional deficiency through supplementation with amino acids and small amounts of electrolytes

View approved original text

This medication is used to supply amino acids and small amounts of electrolytes to patients who are unable to receive nutritional support orally or via the gastrointestinal tract. It is safe for use in both adults and children over the age of 2 years. It helps improve the patient's nutritional status and effectively provides necessary nutrients.

Dosage and Administration

Adult dosage

The intravenous dose depends on the patient's clinical condition and requirements for amino acids, electrolytes, and fluids (nutritional status and/or the degree of nitrogen catabolism due to disease). ○ Children 14 years and older and adults: -Daily dose: Administer 1~2 g of amino acids per kg of body weight daily. This corresponds to 20~40 mL of this medicine per kg of body weight daily; for a patient weighing 70 kg, administer 1,400~2,800 mL daily. -Maximum daily dose: Up to 40 mL (2 g of amino acids) per kg of body weight daily; for a patient weighing 70 kg, up to 2,800 mL (140 g of amino acids) may be administered daily. -Maximum infusion rate: Up to 2 mL (0.1 g of amino acids) per kg of body weight over 1 hour; for a patient weighing 70 kg, this is 45 drops per minute or 2.34 mL. Patients with renal or hepatic impairment The dose should be adjusted accordingly in patients with hepatic or renal failure. This medicine is contraindicated in patients with severe hepatic or renal failure. If the amino acid requirement is 1 g or more per kg of body weight daily, caution should be exercised regarding fluid load; in some cases, this medicine may be replaced with a solution with a higher amino acid concentration. Administer by intravenous infusion. This medicine may be administered through a peripheral vein.

Children's dosage

Children aged 2 years or older and younger than 5 years: 30 mL (1.5 g of amino acids) per kg of body weight daily. Children aged 5 years or older and younger than 14 years: 20 mL (1.0 g of amino acids) per kg of body weight daily. The maximum infusion rate in children aged 2 years or older and younger than 14 years is up to 2 mL (0.1 g of amino acids) per kg of body weight over 1 hour. For critically ill children (aged 2 years or older and younger than 12 years), a higher dose of amino acids may be required (up to 3.0 g of amino acids/kg body weight daily).

Precautions

This medication must be used according to a doctor's instructions. It should not be used in patients who have allergies to any of its components or those with congenital defects in amino acid metabolism. It should not be administered to patients with severe cardiovascular issues, insufficient oxygen supply, metabolic acidosis, or severe liver or kidney dysfunction. Infants under 2 years old or patients where infusion therapy is contraindicated, such as those with heart failure or acute pulmonary failure, should not use this medication. Patients with fluid and electrolyte imbalances must correct these before administration, and in cases of renal failure, the dosage must be adjusted according to the patient's condition. Caution should be exercised when administering to patients with heart or liver failure, and routine blood tests should be conducted to monitor liver function, kidney function, and electrolyte concentrations during administration. At the time of administration, there may be adverse reactions such as nausea, vomiting, allergic reactions, pain, or inflammation at the injection site, so care is required. During pregnancy, the safety of this medication has not been fully proven; it should only be used if the benefits outweigh the risks. During breastfeeding, amino acids may be transmitted through breast milk, but breastfeeding should not be encouraged while receiving non-oral nutrition. In cases of overdose, symptoms such as fluid overload, electrolyte imbalance, pulmonary edema, nausea, vomiting, and headaches may occur, so the administration rate should be adjusted and stopped if necessary. This medication is for single use only and should only be used when the solution is clear or pale yellow; it should be used immediately after opening. When administering, sterile infusion sets should be used, and catheter infections should be checked daily. When mixing with glucose, lipids, vitamins, electrolytes, trace elements, etc., careful mixing in a sterile manner should be done, and it should not be mixed with other medications.

Side effects

  • Allergic reaction
  • nausea
  • vomiting
  • localized pain
  • venous irritation
  • phlebitis
  • overhydration
  • electrolyte imbalance
  • pulmonary edema
  • chills
Show 4 more
  • headache
  • metabolic acidosis
  • hyperammonemia
  • renal amino acid loss

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container, maintaining a temperature between 1 degree and 25 degrees Celsius. Also, care must be taken to avoid freezing the medication.

Appearance and packaging

Appearance

A colorless transparent or pale yellow aqueous solution in a colorless transparent glass vial.

Package unit

250 ml/bottle, 500 ml/bottle, 1000 ml/bottle

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.